Association for Behavior Analysis International

The Association for Behavior Analysis International® (ABAI) is a nonprofit membership organization with the mission to contribute to the well-being of society by developing, enhancing, and supporting the growth and vitality of the science of behavior analysis through research, education, and practice.

Search

45th Annual Convention; Chicago, IL; 2019

Event Details

Previous Page

 

Panel #332
CE Offered: BACB — 
Ethics
The Compelling Case for Clinical Prescription: Practical Interventions for Aligning Caregivers and Clinicians
Sunday, May 26, 2019
5:00 PM–5:50 PM
Hyatt Regency West, Ballroom Level, Regency Ballroom B
Area: AUT/OBM; Domain: Service Delivery
CE Instructor: Gina Chang, Ph.D.
Chair: Kristine Rodriguez (Autism Learning Partners)
GINA CHANG (Autism Learning Partners)
SARAH TORGRIMSON (Autism Learning Partners)
MEGAN ROSE DIMARTINO (Autism Learning Partners)
Abstract:

In the context of medically necessary treatment for Autism Spectrum Disorders, the intensity of service delivery translates to a clinical prescription. The panelists will present a case for level of care recommendations that meet rigorous expectations for effective and efficient progress and that align with best practice literature and the Behavior Analyst Certification Board’s Professional and Ethical Compliance Code. The panel will identify common barriers to best practice in prescription intensity and prescription fulfillment (i.e. full utilization of treatment hours prescribed). Barriers will be categorized as impacted by caregiver availability/adherence or behavior analyst’s competency; the panel will explore successful interventions implemented by supervising clinicians and organizational leaders to improve prescription fulfillment and to align treatment recommendations. At the conclusion of the presentation, participants will be able to: create alignment between ethical values and prescription practices, analyze organizational data to identify relevant barriers, and describe 6 barrier-specific interventions that can be implemented immediately to improve prescription adherence.

Instruction Level: Intermediate
Target Audience:

Behavior Analysts

Learning Objectives: At the conclusion of the presentation, participants will be able to: create alignment between ethical values and prescription practices, analyze organizational data to identify relevant barriers, and describe 6 barrier-specific interventions that can be implemented immediately to improve prescription adherence.
Keyword(s): clinical prescription, treatment efficacy, treatment efficiency
 

BACK TO THE TOP

 

Back to Top
Modifed by Eddie Soh
SABA DONATE